Severe aortic regurgitation secondary to antisynthetase syndrome

Circulation

Volumn 124, Issue 3, 2011, Pages

  Ketlogetswe, Kerunne S ^a   Aoki, Joseph ^b   Traill, Thomas A ^a   Cingolani, Oscar H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ANTISYNTHETASE SYNDROME; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYOSITIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79961085819     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.010066     Document Type: Article

References (2)

1. Imbert-Masseau A, Hamidou M, Agard C, Grolleau J-Y, Cherin P. Antisynthetase syndrome. Joint Bone Spine. 2003;70:161-168. (Pubitemid 36753467)
2. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70:360-374.